Fetal testing in postdates.

P D Bobby; M Y Divon

Home/Archive/PubMed

PubMed · 9204226

Fetal testing in postdates.

P D Bobby·M Y Divon

View original source ↗Export metadata ↓

Abstract

Postdate pregnancies are at significant risk for perinatal morbidity. Fetal testing may be used to observe the prolonged pregnancy safely while awaiting onset of labor. Pitfalls associated with the use of fetal testing in this situation are discussed. The current literature addressing these problems is reviewed.

Explore related subjects

Amniotic Fluid Female Fetal Diseases Gestational Age Humans Incidence Pregnancy Pregnancy, Prolonged Prenatal Diagnosis Risk Factors Survival Rate Ultrasonography, Doppler Ultrasonography, Prenatal Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P D Bobby, M Y Divon. 1997. Fetal testing in postdates.. https://pubmed.ncbi.nlm.nih.gov/9204226/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection.

In this work, we show that the determination of the anticytomegalovirus antibody avidity carried out before week 18 of gestation is a helpful tool to identify women for enrollment in prenatal diagnosis. This procedure can identify all pregnant women who will give birth to an infected newborn.

Amniotic Fluid↗

PubMed1999

Factors influencing pulmonary surfactant protein A levels in cord blood, maternal blood and amniotic fluid.

The purpose of this study was to evaluate factors that influence pulmonary surfactant protein A (SP-A) levels in cord blood, maternal blood and amniotic fluid, as well as to establish the normal range of serum SP-A. Labor significantly influenced cord blood SP-A levels. The SP-A levels in maternal blood after delivery were correlated with, but higher than those before delivery. There was a correlation between SP-A levels in amniotic fluid and cord blood. Neonatal serum SP-A was not correlated with maternal SP-A levels. The normal range of SP-A in cord blood was 2.7-21.7 ng/ml following cesarean section without labor, 4.8-50.2 ng/ml after labor at gestational weeks 36-38, and 12.2-44.6 ng/ml at gestational weeks 39-41. SP-A levels in maternal blood before and after delivery and amniotic fluid were 6. 0-74.0, 9.6-73.6 and 403.4-24,540 ng/ml, respectively.

Amniotic Fluid↗

PubMed1999

Translocation trisomy dup(21q) and free trisomy 21 can be distinguished by interphase-FISH.

The possibility of distinguishing in routine diagnostics translocation trisomy dup(21q) from disomy 21 as well as from free trisomy 21 using interphase fluorescence in situ hybridization (FISH) with a single copy probe (LSI 21) localized on chromosome 21q22.13-q22.2 is described. In free trisomy 21 and translocation trisomy dup(21q) 94%-98% of the nuclei exhibit 3 specific signals, while in disomy 21 only up to 6% of them have 3 false positive signals. Furthermore, reliable differentiation between free and translocation trisomy dup(21q) can be achieved by evaluating the percentage of nuclei with one single and two co-localized chromosome 21q22.13-q22.2 specific signals in 50-100 interphase nuclei. While in translocation trisomy 75+/-4.3% are co-localized due to a chromosomal rearrangement, in free trisomy 21 only 40+/-2.83% of the nuclei have two co-localized signals by chance. No differences in interphase signal distribution could be detected in two cases with a dicentric chromosome dup(21q) compared to one case with a monocentric one, a comparison not previously carried out. In addition, the single copy probe LSI 21 was compared with the alphoid probe D13Z1/D21Z1 which was found to be unsuitable for such assays due to polymorphisms in the á satellite regions of chromosome 21.

Amniotic Fluid↗